Kian Beyzavi, PhD, currently serves as an Independent Board Member at Bone Health Technologies and Inflammatix, Inc., where the focus is on diagnostic innovations. Kian has been the President of Danaee Advisors since 2010, specializing in the development and commercialization of technologies for life science and high-tech sectors. Previous roles include Board Observer and Investor positions at Activ Surgical, Excision BioTherapeutics, and Bioniz Therapeutics, as well as Board Member at Vave Health, known for its advancements in point-of-care ultrasound. Kian contributed to Cota Capital as an Advisor and Venture Partner, emphasizing health technology innovation. Kian's past experience includes serving as Vice President of Global Marketing at Novartis Diagnostics, overseeing global commercial operations. Educational qualifications include a Ph.D. in Electrical Engineering and Applied Physics from Princeton University, along with a Bachelor's and Master's of Electrical Engineering from the University of Minnesota.
This person is not in the org chart
This person is not in any teams